People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stabilux Biosciences, Inc. | — | Biotechnology | Pre-Seed | $554K | $2.9M | 2024 |
JONATHAN KHIN LEINONEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JONATHAN KHIN LEINONEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| YOKE KHIN YAP | 1 | 1 |
| MICHAEL KHIN MORTLOCK | 1 | 1 |
| MARK KHIN EHLERT | 1 | 1 |
| STEVE KHIN TOKARZ | 1 | 1 |
| JOHN KHIN RANSOM | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.